C.J.A. Punt
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 13
- HER2/EGFR in Cancer Research 2
-
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Murielle Mauer (2 shared papers)Frits van Coevorden (2 shared papers)Jonathan A. Ledermann (2 shared papers)Bernard Nordlinger (2 shared papers)P. M. Schlag (1 shared paper)Erik H.J.G. Aarntzen (2 shared papers)Carl G. Figdor (2 shared papers)Halfdan Sørbye (1 shared paper)
- Journals
- European Journal of Cancer (7 papers)Annals of Oncology (5 papers)Journal of Clinical Oncology (2 papers)HPB (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- NetherlandsUnited KingdomFrance
In The Last Decade
C.J.A. Punt
25 papers receiving 612 citations
Peers
Comparison fields: 5 of 63
- Hepatology 171
- Genetics 161
- Oncology 299
- Pulmonary and Respiratory Medicine 216
- Cancer Research 75
Countries citing papers authored by C.J.A. Punt
This map shows the geographic impact of C.J.A. Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J.A. Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J.A. Punt more than expected).
Fields of papers citing papers by C.J.A. Punt
This network shows the impact of papers produced by C.J.A. Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J.A. Punt. The network helps show where C.J.A. Punt may publish in the future.
Co-authors
The 25 scholars most cited alongside C.J.A. Punt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 161 | |
| 2 | 1998 | 156 | |
| 3 | 2008 | 76 | |
| 4 | 2015 | 43 | |
| 5 | 2013 | 32 | |
| 6 | 2015 | 29 | |
| 7 | 2024 | 27 | |
| 8 | 1998 | 14 | |
| 9 | 2006 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2007 | 10 | |
| 12 | Treatment of liver metastases from colorectal cancer. | 2006 | 9 |
| 13 | 2009 | 9 | |
| 14 | Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report. | 2009 | 7 |
| 15 | 2014 | 6 | |
| 16 | 2014 | 6 | |
| 17 | 2003 | 3 | |
| 18 | Trombo-embolische complicaties van centraal-veneuze katheters | 1996 | 2 |
| 19 | 2009 | 2 | |
| 20 | 2009 | 2 |
About C.J.A. Punt
C.J.A. Punt is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Molecular Biology, having authored 26 papers that have together received 624 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Gastric Cancer Management and Outcomes (4 papers), Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (2 papers), T-cell and B-cell Immunology (2 papers) and Colorectal and Anal Carcinomas (2 papers). The work is most often cited by research in Hepatology (171 citations), Genetics (161 citations), Oncology (299 citations), Pulmonary and Respiratory Medicine (216 citations) and Cancer Research (75 citations). C.J.A. Punt has collaborated with scholars based in Netherlands, United Kingdom and France. Frequent co-authors include Murielle Mauer, Frits van Coevorden, Jonathan A. Ledermann, Bernard Nordlinger, P. M. Schlag, Erik H.J.G. Aarntzen, Carl G. Figdor, Halfdan Sørbye, E. Tanis and Thomas Gruenberger. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, HPB and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.